Suppr超能文献

血清淀粉样蛋白 A 与人cystatin C 的相互作用--结合位点的鉴定。

Interaction of serum amyloid A with human cystatin C--identification of binding sites.

机构信息

Department of Medicinal Chemistry, University of Gdansk, Sobieskiego 18, 80-952 Gdansk, Poland.

出版信息

J Mol Recognit. 2012 Oct;25(10):513-24. doi: 10.1002/jmr.2220.

Abstract

Serum amyloid A (SAA) is a multifunctional acute-phase protein whose natural role seems to be participation in many physiologic and pathological processes. Prolonged increased SAA level in a number of chronic inflammatory and neoplastic diseases gives rise to reactive systemic amyloid A amyloidosis, where the N-terminal 76-amino acid residue-long segment of SAA is deposited as amyloid fibrils. Recently, a specific interaction between SAA and the ubiquitous inhibitor of cysteine proteases--human cystatin C (hCC)--has been described. Here, we report further evidence corroborating this interaction, and the identification of the SAA and hCC binding sites in the SAA-hCC complex, using a combination of selective proteolytic excision and high-resolution mass spectrometry. The shortest binding site in the SAA sequence was determined as SAA(86-104), whereas the binding site in hCC sequence was identified as hCC(96-102). Binding specificities of both interacting sequences were ascertained by affinity experiments (ELISA) and by registration of mass spectrum of SAA-hCC complex.

摘要

血清淀粉样蛋白 A(SAA)是一种多功能的急性期蛋白,其天然作用似乎是参与许多生理和病理过程。在许多慢性炎症性和肿瘤性疾病中,SAA 水平持续升高导致反应性系统性淀粉样 A 淀粉样变性,其中 SAA 的 N 端 76 个氨基酸残基长片段作为淀粉样纤维沉积。最近,已经描述了 SAA 与普遍存在的半胱氨酸蛋白酶抑制剂-人半胱氨酸蛋白酶抑制剂 C(hCC)之间的特异性相互作用。在这里,我们使用选择性蛋白水解切除和高分辨率质谱法的组合,进一步报告了证实这种相互作用的证据,并鉴定了 SAA-hCC 复合物中的 SAA 和 hCC 结合位点。SAA 序列中的最短结合位点确定为 SAA(86-104),而 hCC 序列中的结合位点鉴定为 hCC(96-102)。通过亲和实验(ELISA)和 SAA-hCC 复合物的质谱注册确定了两个相互作用序列的结合特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验